HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia
de Barrios O, Ocón-Gabarró I, Gusi-Vives M, Collazo O, Meler A, Romecín PA, Martínez-Moreno A, Tejedor JR, Fraga MF, Schneider P, Bardini M, Cazzaniga G, Marschalek R, Stam RW, Bueno C, Menéndez P, Parra M. Biomark Res. 2025 Jul 28;13(1):99. doi: 10.1186/s40364-025-00810-1. PMID: 40722046 Free PMC article. La revista National Library [...]




